Akili Interactive Labs
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Akili Interactive Labs
There are fewer than a handful of approved prescription video game digital therapeutics, but gamification in patient care is proving its worth as a novel way of treating a range of conditions, from vision loss to dyslexia and ADHD. Now, the onus is on lawmakers and insurers to create a clear path towards reimbursement.
The UK’s PureTech and US biotech Nektar have ended discussions about a potential merger which analysts did not see coming, but a deal could still happen and other companies may also make a move.
The US biotech saw a net loss last year despite increased sales and has decided to focus more on its wholly owned pipeline, which includes a safer formulation of a Roche pulmonary fibrosis product.
Digital neurotherapeutics company MindMaze plans to use the new funding to ramp up commercialization and expand its footprint in the US, also aided by a new partnership with the American Hospital Association.
- Digital Health
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Rehabilitation Equipment and Devices
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.